Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer.

Grosselin K, Durand A, Marsolier J, Poitou A, Marangoni E, Nemati F, Dahmani A, Lameiras S, Reyal F, Frenoy O, Pousse Y, Reichen M, Woolfe A, Brenan C, Griffiths AD, Vallot C, Gérard A.

Nat Genet. 2019 Jun;51(6):1060-1066. doi: 10.1038/s41588-019-0424-9. Epub 2019 May 31.

PMID:
31152164
2.

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.

de Koning L, Decaudin D, El Botty R, Nicolas A, Carita G, Schuller M, Ouine B, Cartier A, Naguez A, Fleury J, Cooke V, Wylie A, Smith P, Marangoni E, Gentien D, Meseure D, Mariani P, Cassoux N, Piperno-Neumann S, Roman-Roman S, Némati F.

Cancers (Basel). 2019 May 29;11(6). pii: E751. doi: 10.3390/cancers11060751.

3.

Pyrolysis of functional cellulose by ionothermal method to synthesis of mesoporous triazine carbon for supporting of Pd and its application.

Mirhosseyni MS, Nemati F, Elhampour A.

Carbohydr Polym. 2019 Aug 1;217:199-206. doi: 10.1016/j.carbpol.2019.04.005. Epub 2019 Apr 17.

PMID:
31079677
4.

A ratiometric probe based on Ag2S quantum dots and graphitic carbon nitride nanosheets for the fluorescent detection of Cerium.

Nemati F, Zare-Dorabei R.

Talanta. 2019 Aug 1;200:249-255. doi: 10.1016/j.talanta.2019.03.059. Epub 2019 Mar 15.

PMID:
31036181
5.

Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers.

Vinet M, Suresh S, Maire V, Monchecourt C, Némati F, Lesage L, Pierre F, Ye M, Lescure A, Brisson A, Meseure D, Nicolas A, Rigaill G, Marangoni E, Del Nery E, Roman-Roman S, Dubois T.

Cancer Med. 2019 May;8(5):2414-2428. doi: 10.1002/cam4.2114. Epub 2019 Apr 8.

6.

Investigation of indolamine 2, 3 dioxygenase (IDO-1) gene expression by real-time PCR among patients with lung cancer.

Haji Mazdarani M, Jafarikia M, Nemati F.

J Cell Physiol. 2019 Aug;234(8):13781-13787. doi: 10.1002/jcp.28057. Epub 2019 Jan 22.

PMID:
30671955
7.

Albumin binding, anticancer and antibacterial properties of synthesized zero valent iron nanoparticles.

Anbouhi TS, Esfidvajani EM, Nemati F, Haghighat S, Sari S, Attar F, Pakaghideh A, Sohrabi MJ, Mousavi SE, Falahati M.

Int J Nanomedicine. 2018 Dec 28;14:243-256. doi: 10.2147/IJN.S188497. eCollection 2019.

8.

LRP8 is overexpressed in estrogen-negative breast cancers and a potential target for these tumors.

Maire V, Mahmood F, Rigaill G, Ye M, Brisson A, Némati F, Gentien D, Tucker GC, Roman-Roman S, Dubois T.

Cancer Med. 2019 Jan;8(1):325-336. doi: 10.1002/cam4.1923. Epub 2018 Dec 21.

9.
10.

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers.

Gentric G, Kieffer Y, Mieulet V, Goundiam O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, Lallemand-Breitenbach V, Müller S, Cañeque T, Rodriguez R, Vincent-Salomon A, de Thé H, Rossignol R, Mechta-Grigoriou F.

Cell Metab. 2019 Jan 8;29(1):156-173.e10. doi: 10.1016/j.cmet.2018.09.002. Epub 2018 Sep 20.

11.

A Simple and One-pot Synthesis of Tetrahydrobenzo[b]pyrans and Spirooxindoles Catalyzed by H-Fe3O4@DA-SO3H as an Efficient, Light and Reusable Nanocatalyst.

Mirhosseyni MS, Nemati F, Elhampour A.

Comb Chem High Throughput Screen. 2018;21(7):487-494. doi: 10.2174/1386207321666180817142658.

PMID:
30117389
12.

Titanium oxide nanoparticles fabrication, hemoglobin interaction, white blood cells cytotoxicity, and antibacterial studies.

Abdolmajid E, Kharazi H, Chalaki M, Khojasteh M, Haghighat S, Attar F, Nemati F, Falahati M.

J Biomol Struct Dyn. 2019 Jul;37(11):3007-3017. doi: 10.1080/07391102.2018.1499555. Epub 2018 Dec 5.

PMID:
30044173
13.

Magnetic chitosan composite as a green support for anchoring diphenyl diselenide as a biocatalyst for the oxidation of sulfides.

Rangraz Y, Nemati F, Elhampour A.

Int J Biol Macromol. 2018 Oct 1;117:820-830. doi: 10.1016/j.ijbiomac.2018.05.207. Epub 2018 May 29.

PMID:
29857110
14.

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.

Maubant S, Tahtouh T, Brisson A, Maire V, Némati F, Tesson B, Ye M, Rigaill G, Noizet M, Dumont A, Gentien D, Marty-Prouvost B, de Koning L, Mahmood SF, Decaudin D, Cruzalegui F, Tucker GC, Roman-Roman S, Dubois T.

Oncotarget. 2018 Apr 27;9(32):22586-22604. doi: 10.18632/oncotarget.25187. eCollection 2018 Apr 27.

15.

Selumetinib-based therapy in uveal melanoma patient-derived xenografts.

Decaudin D, El Botty R, Diallo B, Massonnet G, Fleury J, Naguez A, Raymondie C, Davies E, Smith A, Wilson J, Howes C, Smith PD, Cassoux N, Piperno-Neumann S, Roman-Roman S, Némati F.

Oncotarget. 2018 Apr 24;9(31):21674-21686. doi: 10.18632/oncotarget.24670. eCollection 2018 Apr 24.

16.

A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women.

Broumand F, Lak SS, Nemati F, Mazidi A.

Electron Physician. 2018 Jan 25;10(1):6186-6192. doi: 10.19082/6186. eCollection 2018 Jan.

17.

Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers.

Marangoni E, Laurent C, Coussy F, El-Botty R, Château-Joubert S, Servely JL, de Plater L, Assayag F, Dahmani A, Montaudon E, Nemati F, Fleury J, Vacher S, Gentien D, Rapinat A, Foidart P, Sounni NE, Noel A, Vincent-Salomon A, Lae M, Decaudin D, Roman-Roman S, Bièche I, Piccart M, Reyal F.

Clin Cancer Res. 2018 Jun 1;24(11):2605-2615. doi: 10.1158/1078-0432.CCR-17-3490. Epub 2018 Feb 20.

18.

Silver(I) dithiocarbamate on modified magnetic cellulose: Synthesis, density functional theory study and application.

Sabaqian S, Nemati F, Nahzomi HT, Heravi MM.

Carbohydr Polym. 2018 Mar 15;184:221-230. doi: 10.1016/j.carbpol.2017.12.045. Epub 2017 Dec 21.

PMID:
29352915
19.

Glutathione conjugated polyethylenimine on the surface of Fe3O4 magnetic nanoparticles as a theranostic agent for targeted and controlled curcumin delivery.

Aeineh N, Salehi F, Akrami M, Nemati F, Alipour M, Ghorbani M, Nikfar B, Salehian F, Riyahi Alam N, Sadat Ebrahimi SE, Foroumadi A, Khoobi M, Rouini M, Dibaei M, Haririan I, Ganjali MR, Safaei S.

J Biomater Sci Polym Ed. 2018 Jul;29(10):1109-1125. doi: 10.1080/09205063.2018.1427013. Epub 2018 Feb 16.

PMID:
29320951
20.

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.

Bougherara H, Némati F, Nicolas A, Massonnet G, Pugnière M, Ngô C, Le Frère-Belda MA, Leary A, Alexandre J, Meseure D, Barret JM, Navarro-Teulon I, Pèlegrin A, Roman-Roman S, Prost JF, Donnadieu E, Decaudin D.

Oncotarget. 2017 Oct 7;8(59):99950-99965. doi: 10.18632/oncotarget.21556. eCollection 2017 Nov 21.

21.

Palladium acetate supported on amidoxime-functionalized magnetic cellulose: Synthesis, DFT study and application in Suzuki reaction.

Sabaqian S, Nemati F, Nahzomi HT, Heravi MM.

Carbohydr Polym. 2017 Dec 1;177:165-177. doi: 10.1016/j.carbpol.2017.08.109. Epub 2017 Aug 31.

PMID:
28962755
22.

Diphenyl diselenide immobilized on magnetic nanoparticles: A novel and retrievable heterogeneous catalyst in the oxidation of aldehydes under mild and green conditions.

Rangraz Y, Nemati F, Elhampour A.

J Colloid Interface Sci. 2018 Jan 1;509:485-494. doi: 10.1016/j.jcis.2017.09.034. Epub 2017 Sep 8.

PMID:
28923746
23.

Synthesis of 2 carbon-14 analogue of thioflavanones.

Basooti M, Saadatjoo N, Nemati F, Shirvani G, Faghih MAA, Javaheri M.

J Labelled Comp Radiopharm. 2017 Sep;60(11):550-552. doi: 10.1002/jlcr.3533. Epub 2017 Aug 29.

PMID:
28631832
24.

A spectroscopic study on the absorption of carbonic anhydrase onto the nanoporous silica nanoparticle.

Khameneh HP, Bolouri TG, Nemati F, Rezvani F, Attar F, Saboury AA, Falahati M.

Int J Biol Macromol. 2017 Jun;99:739-745. doi: 10.1016/j.ijbiomac.2017.03.030. Epub 2017 Mar 8.

PMID:
28283456
25.

Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.

Crépin R, Gentien D, Duché A, Rapinat A, Reyes C, Némati F, Massonnet G, Decaudin D, Djender S, Moutel S, Desrumeaux K, Cassoux N, Piperno-Neumann S, Amigorena S, Perez F, Roman-Roman S, de Marco A.

Pigment Cell Melanoma Res. 2017 May;30(3):317-327. doi: 10.1111/pcmr.12577. Epub 2017 Apr 19.

PMID:
28140525
26.

Measurements of donor endothelial keratoplasty lenticules prepared from fresh donated whole eyes by using ultrasound and optical coherence tomography.

Kanavi MR, Nemati F, Chamani T, Kheiri B, Javadi MA.

Cell Tissue Bank. 2017 Mar;18(1):99-104. doi: 10.1007/s10561-016-9599-9. Epub 2016 Nov 12.

PMID:
27838813
27.

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

van Essen TH, van Pelt SI, Bronkhorst IH, Versluis M, Némati F, Laurent C, Luyten GP, van Hall T, van den Elsen PJ, van der Velden PA, Decaudin D, Jager MJ.

PLoS One. 2016 Oct 20;11(10):e0164292. doi: 10.1371/journal.pone.0164292. eCollection 2016.

28.

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.

Carita G, Frisch-Dit-Leitz E, Dahmani A, Raymondie C, Cassoux N, Piperno-Neumann S, Némati F, Laurent C, De Koning L, Halilovic E, Jeay S, Wylie A, Emery C, Roman-Roman S, Schoumacher M, Decaudin D.

Oncotarget. 2016 Jun 7;7(23):33542-56. doi: 10.18632/oncotarget.9552.

29.

Uveal Melanoma Patient-Derived Xenografts.

Carita G, Némati F, Decaudin D.

Ocul Oncol Pathol. 2015 Apr;1(3):161-9. doi: 10.1159/000370154. Epub 2015 Apr 9. Review.

30.

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma.

Amirouchene-Angelozzi N, Frisch-Dit-Leitz E, Carita G, Dahmani A, Raymondie C, Liot G, Gentien D, Némati F, Decaudin D, Roman-Roman S, Schoumacher M.

Oncotarget. 2016 Apr 26;7(17):23633-46. doi: 10.18632/oncotarget.8054.

31.

TIPIN depletion leads to apoptosis in breast cancer cells.

Baldeyron C, Brisson A, Tesson B, Némati F, Koundrioukoff S, Saliba E, De Koning L, Martel E, Ye M, Rigaill G, Meseure D, Nicolas A, Gentien D, Decaudin D, Debatisse M, Depil S, Cruzalegui F, Pierré A, Roman-Roman S, Tucker GC, Dubois T.

Mol Oncol. 2015 Oct;9(8):1580-98. doi: 10.1016/j.molonc.2015.04.010. Epub 2015 May 9.

32.

Enhanced serum proteolysis resistance of cell-penetrating peptides.

Fominaya J, Bravo J, Decaudin D, Brossa JY, Nemati F, Rebollo A.

Ther Deliv. 2015 Feb;6(2):139-47. doi: 10.4155/tde.14.100.

PMID:
25690083
33.

Cell penetrating peptides as a therapeutic strategy in chronic lymphocytic leukemia.

Arrouss I, Decaudin D, Choquet S, Azar N, Parizot C, Zini JM, Nemati F, Rebollo A.

Protein Pept Lett. 2015;22(6):539-46.

PMID:
25687226
34.

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.

Stimmer L, Dehay S, Nemati F, Massonnet G, Richon S, Decaudin D, Klijanienko J, Johannes L.

BMC Cancer. 2014 Dec 4;14:916. doi: 10.1186/1471-2407-14-916.

35.

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Amirouchene-Angelozzi N, Nemati F, Gentien D, Nicolas A, Dumont A, Carita G, Camonis J, Desjardins L, Cassoux N, Piperno-Neumann S, Mariani P, Sastre X, Decaudin D, Roman-Roman S.

Mol Oncol. 2014 Dec;8(8):1508-20. doi: 10.1016/j.molonc.2014.06.004. Epub 2014 Jun 13.

36.

Cytotoxic properties of some medicinal plant extracts from mazandaran, iran.

Nemati F, Dehpouri AA, Eslami B, Mahdavi V, Mirzanejad S.

Iran Red Crescent Med J. 2013 Nov;15(11):e8871. doi: 10.5812/ircmj.8871. Epub 2013 Nov 5.

37.

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.

Bieche I, Vacher S, Vallerand D, Richon S, Hatem R, De Plater L, Dahmani A, Némati F, Angevin E, Marangoni E, Roman-Roman S, Decaudin D, Dangles-Marie V.

BMC Cancer. 2014 Mar 13;14:178. doi: 10.1186/1471-2407-14-178.

38.

Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.

Némati F, de Montrion C, Lang G, Kraus-Berthier L, Carita G, Sastre-Garau X, Berniard A, Vallerand D, Geneste O, de Plater L, Pierré A, Lockhart B, Desjardins L, Piperno-Neumann S, Depil S, Decaudin D.

PLoS One. 2014 Jan 13;9(1):e80836. doi: 10.1371/journal.pone.0080836. eCollection 2014.

39.

Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy.

Arrouss I, Nemati F, Roncal F, Wislez M, Dorgham K, Vallerand D, Rabbe N, Karboul N, Carlotti F, Bravo J, Mazier D, Decaudin D, Rebollo A.

PLoS One. 2013 Apr 23;8(4):e60816. doi: 10.1371/journal.pone.0060816. Print 2013.

40.

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation.

Weiswald LB, Richon S, Massonnet G, Guinebretière JM, Vacher S, Laurendeau I, Cottu P, Marangoni E, Nemati F, Validire P, Bellet D, Bièche I, Dangles-Marie V.

Br J Cancer. 2013 Apr 30;108(8):1720-31. doi: 10.1038/bjc.2013.132. Epub 2013 Mar 28.

41.

Patient-derived xenografts recapitulate molecular features of human uveal melanomas.

Laurent C, Gentien D, Piperno-Neumann S, Némati F, Nicolas A, Tesson B, Desjardins L, Mariani P, Rapinat A, Sastre-Garau X, Couturier J, Hupé P, de Koning L, Dubois T, Roman-Roman S, Stern MH, Barillot E, Harbour JW, Saule S, Decaudin D.

Mol Oncol. 2013 Jun;7(3):625-36. doi: 10.1016/j.molonc.2013.02.004. Epub 2013 Feb 26.

42.

Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters.

Petit V, Massonnet G, Maciorowski Z, Touhami J, Thuleau A, Némati F, Laval J, Château-Joubert S, Servely JL, Vallerand D, Fontaine JJ, Taylor N, Battini JL, Sitbon M, Decaudin D.

Lab Invest. 2013 May;93(5):611-21. doi: 10.1038/labinvest.2013.44. Epub 2013 Mar 4.

43.

Stress and risk avoidance by exploring rats: implications for stress management in fear-related behaviours.

Nemati F, Kolb B, Metz GA.

Behav Processes. 2013 Mar;94:89-98. doi: 10.1016/j.beproc.2012.12.005. Epub 2013 Jan 7.

PMID:
23305801
44.

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Maire V, Némati F, Richardson M, Vincent-Salomon A, Tesson B, Rigaill G, Gravier E, Marty-Prouvost B, De Koning L, Lang G, Gentien D, Dumont A, Barillot E, Marangoni E, Decaudin D, Roman-Roman S, Pierré A, Cruzalegui F, Depil S, Tucker GC, Dubois T.

Cancer Res. 2013 Jan 15;73(2):813-23. doi: 10.1158/0008-5472.CAN-12-2633. Epub 2012 Nov 9.

45.

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C.

Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23.

46.

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

Madic J, Piperno-Neumann S, Servois V, Rampanou A, Milder M, Trouiller B, Gentien D, Saada S, Assayag F, Thuleau A, Nemati F, Decaudin D, Bidard FC, Desjardins L, Mariani P, Lantz O, Stern MH.

Clin Cancer Res. 2012 Jul 15;18(14):3934-41. doi: 10.1158/1078-0432.CCR-12-0309. Epub 2012 May 29.

47.

Recovery from medial prefrontal cortex injury during adolescence: implications for age-dependent plasticity.

Nemati F, Kolb B.

Behav Brain Res. 2012 Apr 1;229(1):168-75. doi: 10.1016/j.bbr.2012.01.002. Epub 2012 Jan 9.

PMID:
22261018
48.

FGF-2 induces behavioral recovery after early adolescent injury to the motor cortex of rats.

Nemati F, Kolb B.

Behav Brain Res. 2011 Nov 20;225(1):184-91. doi: 10.1016/j.bbr.2011.07.023. Epub 2011 Jul 23. Erratum in: Behav Brain Res. 2011 Dec 1;225(2):660.

PMID:
21801753
49.

Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.

Couture O, Dransart E, Dehay S, Nemati F, Decaudin D, Johannes L, Tanter M.

Mol Imaging. 2011 Apr;10(2):135-43.

PMID:
21439258
50.

Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.

Nemati F, Rahbar-Roshandel N, Hosseini F, Mahmoudian M, Shafiei M.

Clin Exp Hypertens. 2011;33(2):66-76. doi: 10.3109/10641963.2010.496521. Epub 2011 Feb 11.

PMID:
21309738

Supplemental Content

Loading ...
Support Center